Literature DB >> 16359791

Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.

M A Hellmann1, H Panet, Y Barhum, E Melamed, D Offen.   

Abstract

Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra. Attempted replacement of these neurons by stem cells has proved inconclusive. Bone marrow mesenchymal stem cells (MSC) are multipotent, differentiating into a variety of cells, including neuron-like cells. We used the 6-hydroxydopamine (6-OHDA) animal model of Parkinson's disease to assess migration and differentiation of transplanted MSC. We found in rodents that transplanted MSC survive better in the 6-OHDA-induced damaged hemisphere compared to the unlesioned side. Moreover, contralaterally engrafted MSC migrated through the corpus callosum to populate the striatum, thalamic nuclei and substantia nigra of the 6-OHDA-lesioned hemisphere. In conclusion, we demonstrate that 6-OHDA-induced damage increases the viability of transplanted MSC and attracts these cells from the opposite hemisphere.

Entities:  

Mesh:

Year:  2005        PMID: 16359791     DOI: 10.1016/j.neulet.2005.10.097

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  44 in total

Review 1.  Stem cell transplantation: a promising therapy for Parkinson's disease.

Authors:  Yi Wang; Sheng Chen; Dehua Yang; Wei-dong Le
Journal:  J Neuroimmune Pharmacol       Date:  2007-05-09       Impact factor: 4.147

2.  Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.

Authors:  Melissa K McCoy; Terina N Martinez; Kelly A Ruhn; Philip C Wrage; Edward W Keefer; Barry R Botterman; Keith E Tansey; Malú G Tansey
Journal:  Exp Neurol       Date:  2007-11-01       Impact factor: 5.330

Review 3.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

4.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 5.  Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.

Authors:  James P Harris; Justin C Burrell; Laura A Struzyna; H Isaac Chen; Mijail D Serruya; John A Wolf; John E Duda; D Kacy Cullen
Journal:  NPJ Parkinsons Dis       Date:  2020-01-08

6.  Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.

Authors:  Jürgen Berg; Manfred Roch; Jennifer Altschüler; Christine Winter; Anne Schwerk; Andreas Kurtz; Barbara Steiner
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

7.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis.

Authors:  Yael Barhum; Sharon Gai-Castro; Merav Bahat-Stromza; Ran Barzilay; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2009-11-10       Impact factor: 3.444

9.  Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model.

Authors:  Erin F Wolff; Xiao-Bing Gao; Katherine V Yao; Zane B Andrews; Hongling Du; John D Elsworth; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

10.  Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease.

Authors:  Dianne M Camp; David A Loeffler; Diane M Farrah; Jade N Borneman; Peter A LeWitt
Journal:  J Neuroinflammation       Date:  2009-06-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.